Outlook Therapeutics, Inc.
OTLK
$0.64
$0.000.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.32M | -4.45M | -23.06M | -13.29M | -20.15M |
| Total Depreciation and Amortization | 13.80K | 30.40K | 30.10K | 29.70K | 29.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.30M | -8.82M | 10.46M | -2.38M | 6.04M |
| Change in Net Operating Assets | -11.01M | 5.41M | -2.37M | 3.26M | 2.19M |
| Cash from Operations | -21.01M | -7.83M | -14.94M | -12.38M | -11.90M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.10M | -- | -- | -- | -- |
| Cash from Investing | -2.10M | -- | -- | -- | -- |
| Total Debt Issued | -17.00M | 17.00M | -- | 0.00 | 0.00 |
| Total Debt Repaid | 17.00M | -17.00M | -- | -2.33M | -907.00K |
| Issuance of Common Stock | 29.51M | 6.90M | 15.53M | 13.89M | 14.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.91M | -- | -- | -- | -448.00K |
| Cash from Financing | 26.60M | 6.90M | 15.53M | 11.56M | 13.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.49M | -929.20K | 594.30K | -817.70K | 1.34M |